• Medientyp: E-Artikel
  • Titel: Approaching Complete Inhibition of P-Glycoprotein at the Human Blood–Brain Barrier: An (R)-[11C]Verapamil PET Study
  • Beteiligte: Bauer, Martin; Karch, Rudolf; Zeitlinger, Markus; Philippe, Cécile; Römermann, Kerstin; Stanek, Johann; Maier-Salamon, Alexandra; Wadsak, Wolfgang; Jäger, Walter; Hacker, Marcus; Müller, Markus; Langer, Oliver
  • Erschienen: SAGE Publications, 2015
  • Erschienen in: Journal of Cerebral Blood Flow & Metabolism
  • Sprache: Englisch
  • DOI: 10.1038/jcbfm.2015.19
  • ISSN: 0271-678X; 1559-7016
  • Schlagwörter: Cardiology and Cardiovascular Medicine ; Neurology (clinical) ; Neurology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p> As P-glycoprotein (Pgp) inhibition at the blood–brain barrier (BBB) after administration of a single dose of tariquidar is transient, we performed positron emission tomography (PET) scans with the Pgp substrate ( R)-[<jats:sup>11</jats:sup>C]verapamil in five healthy volunteers during continuous intravenous tariquidar infusion. Total distribution volume ( V<jats:sub>T</jats:sub>) of ( R)-[<jats:sup>11</jats:sup>C]verapamil in whole-brain gray matter increased by 273 ± 78% relative to baseline scans without tariquidar, which was higher than previously reported V<jats:sub>T</jats:sub> increases. During tariquidar infusion whole-brain V<jats:sub>T</jats:sub> was comparable to V<jats:sub>T</jats:sub> in the pituitary gland, a region not protected by the BBB, which suggested that we were approaching complete Pgp inhibition at the human BBB. </jats:p>
  • Zugangsstatus: Freier Zugang